Larry Biegelsen
Wells Fargo Securities, LLC, Research Division

All right. Good morning. I'm Larry Biegelsen, the Medical Device Analyst at Wells Fargo. Welcome to the final call in our 2026 MedTech Innovation Spotlight Series. I'm pleased to be joined by Inspire Medical's management team. We have Chairman and CEO, Tim Herbert; CFO, Matt Osberg; and Vice President of Investor Relations, Ezgi Yagci.

On today's call, we'll focus on Inspire V, coding and reimbursement, clinical data, competitive market dynamics and the outlook. We're going to start with a short slide presentation by Tim, and then we're going to jump into Q&A. And as always, if anybody has a question they want me to ask on their behalf, please e-mail it to me. Tim, Matt and Ezgi, thanks so much for joining us. You guys have been very strong supporters of this call series. So thank you very much.

Timothy Herbert
Founder, Chairman, CEO & President

Thank you, Larry. We really enjoy this call series, and I think it is the one that can really highlight on innovation and the R&D spotlight. And I think that we value that because we spent so much time on the development of the Inspire system and driving outcomes and positive experiences. And so we put together a couple of slides to really kind of walk through several of the key areas. And I know it's an innovation call. I know it's R&D spotlight, but I think everybody really want to hear an update on the coding.

So we want to -- let's get that out of